跳至主要内容
临床试验/NL-OMON56477
NL-OMON56477招募中不适用

A feasibility study for an e-health blended personalised lifestyle intervention to change lifestyle behaviour and reverse the risk for type 2 diabetes in people with prediabetes. - ELFI Health (Empowerment by Lifestyle, Food advice and Interaction)

TNO0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • To be eligible to participate in this study, a subject must meet all the
  • following criteria:
  • 1. During the information session, health is assessed by the:
  • a. Screening questionnaire (P9885 F02; in Dutch)
  • 2. During the health check, blood measurements are assessed by the
  • point-of-care tool:
  • a. HbA1c: 39 - 53 mmol/mol (= 5.7 - 7.0%)
  • 3. Age between 18 - 70 years
  • 4. Stable BMI of 25 - 35 kg/m2
  • 5. Informed consent signed
  • 6. Willing to comply with the study procedures during the study
  • 7. Being able to become more physically active, as assessed by the screening
  • questionnaire (P9885 F02; in Dutch).
  • 8. Being digitally competent
  • 9. Willing to accept the use of all nameless data, including publication, and
  • the confidential use and storage of all data for at least 15 years

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • 1. Being diagnosed with diabetes type 1 or 2
  • 2. Use of insulin, corticosteroids (systemic), or beta-blockers in past month
  • 3. Use of oral diabetes medication in past year
  • 4. (Having a history of a) medical condition that might significantly affect
  • the study outcome as judged by the general practitioner and health and
  • lifestyle questionnaire. This includes gastrointestinal dysfunction, diseases
  • related to inflammation or allergy, or a psychiatric disorder
  • 5. Being abroad or on vacation for longer than a week.
  • 6. Alcohol consumption > 21 (women) - 28 (men) units/week
  • 7. Reported unexplained weight loss or gain of > 2 kg in the month prior to the
  • pre-study screening
  • 8. Recent blood donation (<1 month prior to the start of the study)
  • 9. Not willing to give up blood donation during the study
  • 10. Not willing to accept information-transfer concerning participation in the
  • study, or information regarding his health, like laboratory results, findings
  • at anamnesis or physical examination and eventual adverse events to and from
  • his general practitioner.
  • 11. Pregnant or lactating women
  • 12. Involved in another GLI or weight loss program
  • 13. On GLP-1 analogues to stimulate weight loss

研究者

发起方
TNO

相似试验